Form 4: Astronics Corp. Executive Mark Peabody Reports Stock Transactions
SEC Form 4
VP of Astronics Advanced Electronic, Mark Peabody, reports acquisition and disposal of Astronics Corp. stock and stock options related to bonus plans and tax obligations.
Summary
- Mark Peabody, VP of Astronics Advanced Electronic, filed a Form 4 detailing changes in beneficial ownership of Astronics Corp. stock.
- The report includes transactions from March 1, 2024, related to the payout of the 2023 bonus plan in shares of common stock.
- Peabody acquired 251 shares as a Q4 2023 bonus and 13,329 shares as an annual bonus for 2023.
- 76 shares and 4,816 shares were withheld to cover applicable withholding taxes upon the grant of the stock bonus award.
- The report also details Peabody's ownership of various stock options and restricted stock units (RSUs) with different vesting schedules and EBITDA-based performance conditions.
- Vesting of RSUs depends on Astronics Corp.'s average annual adjusted EBITDA for specified periods, with potential vesting percentages ranging from 50% to 150% based on performance.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing, so the sentiment is neutral. The granting of stock bonuses and performance-based RSUs can be seen as a positive sign, but the tax withholding and performance-based vesting introduce some uncertainty.
Positives
- The granting of stock bonuses to executives aligns their interests with those of shareholders.
- Performance-based vesting of restricted stock units incentivizes executives to improve the company's financial performance, specifically adjusted EBITDA.
Negatives
- The withholding of shares to cover taxes reduces the executive's immediate gain from the stock bonus.
- Vesting of restricted stock units is contingent on achieving specific EBITDA targets, which introduces uncertainty.
Risks
- Failure to meet the EBITDA targets could result in lower vesting percentages for the restricted stock units.
- Fluctuations in the stock price could impact the value of the stock options and restricted stock units.
Future Outlook
The vesting of restricted stock units is tied to the company's future EBITDA performance, indicating a focus on achieving specific financial targets.
Industry Context
Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders and incentivize performance.
Comparison to Industry Standards
- Stock options and restricted stock units are common components of executive compensation packages in publicly traded companies.
- Performance-based vesting of RSUs is a standard practice to incentivize executives to achieve specific financial goals.
- Companies like Boeing, Airbus, and other aerospace manufacturers also use similar compensation strategies to motivate their executives.
Stakeholder Impact
- Shareholders: The granting of stock bonuses and performance-based RSUs can align management's interests with those of shareholders.
- Employees: The document does not directly impact other employees, but it provides insight into executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 12/11/2015 | Grant date of some stock options with an exercise price of $30.83 and an expiration date of 12/11/2024 |
| 12/03/2016 | Grant date of some stock options with an exercise price of $27.72 and an expiration date of 12/03/2025 |
| 12/14/2017 | Grant date of some stock options with an exercise price of $31.76 and an expiration date of 12/14/2026 |
| 12/12/2018 | Grant date of some stock options with an exercise price of $35.61 and an expiration date of 12/12/2027 |
| 12/13/2019 | Grant date of some stock options with an exercise price of $31.57 and an expiration date of 12/13/2028 |
| 12/09/2020 | Grant date of some stock options with an exercise price of $30.04 and an expiration date of 12/09/2029 |
| 01/01/2021 | Start date for the period used to calculate average annual adjusted EBITDA for some restricted stock units. |
| 01/22/2022 | Grant date of some stock options with an exercise price of $14.45 and an expiration date of 01/22/2031 |
| 01/01/2022 | Start date for the period used to calculate average annual adjusted EBITDA for some restricted stock units. |
| 12/09/2022 | Grant date of some stock options with an exercise price of $11.13 and an expiration date of 12/09/2031 |
| 01/01/2023 | Start date for the period used to calculate average annual adjusted EBITDA for some restricted stock units. |
| 12/16/2023 | Grant date of some stock options with an exercise price of $9.74 and an expiration date of 12/16/2032 |
| 12/31/2023 | End date for the period used to calculate average annual adjusted EBITDA for some restricted stock units. |
| 01/01/2024 | Start date for the period used to calculate average annual adjusted EBITDA for some restricted stock units. |
| 03/01/2024 | Date of the reported transactions involving stock acquisition and disposal. |
| 12/07/2024 | Grant date of some stock options with an exercise price of $15.15 and an expiration date of 12/07/2033 |
| 02/24/2025 | Potential vesting date for some restricted stock units, dependent on EBITDA performance. |
| 02/23/2026 | Potential vesting date for some restricted stock units, dependent on EBITDA performance. |
| 12/31/2026 | End date for the period used to calculate average annual adjusted EBITDA for some restricted stock units. |
| 02/22/2027 | Potential vesting date for some restricted stock units, dependent on EBITDA performance. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.